mRNA-based personalized cancer vaccines: opportunities, challenges and outcomes
Acta Naturae · 04.12.2025 · 17 (4) · 17-37
DOI: 10.32607/actanaturae.27707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Naturae, online erschienen am 04.12.2025. Verfasst von A A Ibragimova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, 634009 Russia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
mRNA-based cancer vaccines represent an innovative approach to cancer treatment. Cancer mRNA vaccines are structurally based on specific tumor antigens, a technique which enables the patient’s immune system to become activated against cancer cells. Clinical trials of mRNA vaccines against various types of tumors, including melanoma, lung cancer, pancreatic carcinoma, breast cancer and others, are currently underway. Because of their favorable safety profile and adaptability, these therapeutics hold considerable promise in efforts to enhance cancer treatment efficacy and prolong patient life. This review outlines steps in the development of manufacturing technologies for mRNA-based therapeutics, describes the algorithm used to design personalized anti-tumor mRNA vaccines, discusses their practical implementation, and summarizes current clinical trials in cancer immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, 634009 Russia.
- Center for Systems Bioinformatics, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, 634050 Russia.
Zitieren
APA
Ibragimova, A. A., Fedorov, A. A., Kirilenko, K. M., Choynzonov, E. L., Denisov, E. V., & Patysheva, M. R. (2025). mRNA-based personalized cancer vaccines: opportunities, challenges and outcomes. Acta Naturae, 17(4), 17-37. https://doi.org/10.32607/actanaturae.27707
Vancouver
Ibragimova AA, Fedorov AA, Kirilenko KM, Choynzonov EL, Denisov EV, Patysheva MR. mRNA-based personalized cancer vaccines: opportunities, challenges and outcomes. Acta Naturae. 2025;17(4):17-37. doi:10.32607/actanaturae.27707
BibTeX
@article{Ibragimova2025,
author = {Ibragimova, A A and Fedorov, A A and Kirilenko, K M and Choynzonov, E L and Denisov, E V and Patysheva, M R},
title = {mRNA-based personalized cancer vaccines: opportunities, challenges and outcomes},
journal = {Acta Naturae},
year = {2025},
volume = {17},
number = {4},
pages = {17--37},
doi = {10.32607/actanaturae.27707}
}
EUVIMED